Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors

Paclitaxel is one of the most widely used chemotherapeutic agents thanks to its effectiveness and broad spectrum of antitumor activity. However, it has a very poor aqueous solubility and a limited specificity. To solve these handicaps, a novel paclitaxel-trastuzumab targeted transport nanosystem has...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieto, Celia, Centa, Ariana, Rodríguez-Rodríguez, Jesús A., Pandiella, Atanasio, Martín del Valle, Eva M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669497/
https://www.ncbi.nlm.nih.gov/pubmed/31261957
http://dx.doi.org/10.3390/nano9070948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669497/
https://www.ncbi.nlm.nih.gov/pubmed/31261957
http://dx.doi.org/10.3390/nano9070948

Ejemplares similares